Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension
US9115082B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Inventors
Key dates
| Filing date | Jan 18, 2013 |
| Grant date | Aug 25, 2015 |
| Priority date | — |
| Expiry date | Jan 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/192
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention comprises novel inhibitors of dipeptidyl peptidase IV (DPP-IV) with beta blocker activity, pharmaceutical compositions comprising therapeutically effective amounts of novel inhibitors of DPP-IV, and novel methods of treating medical conditions are provided. The novel inhibitors of DPP-IV described herein are useful in the treatment of neurological disorders, diabetes, inflammatory disorders such as arthritis, obesity, osteoporosis, hypertension, and glaucoma of such other enumerated conditions as can be treated with inhibitors of DPP-IV and beta blockers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.